Abstract: Cardiac osteosarcoma metastasis is extremely rare and is documented in several case reports in the literature. The behaviour of osteosarcoma metastases is similar to the primary tumour. Thoracic non-enhanced computed tomography (CT) examination is beneficial in the detection of calcific cardiac metastases. In this case report, we describe a 29-year-old woman with cardiac osteosarcoma metastasis after 7 years of follow-up, compare the demographic features with previous cases and discuss the imaging findings.
Introduction
Neoplasms of the heart are rare tumours that can be primary or secondary. Metastatic cardiac neoplasms are approximately 30 times more frequent than primary tumours. The frequency of metastatic cardiac tumours varies according to patient age. Osteosarcoma metastasis of the heart is extremely rare and has been documented in young adults as shown in a number of case reports. Along with improvements in chemotherapy protocols and increasing survival rates in osteosarcoma patients, a corresponding increase in antemortem diagnoses of late cardiac metastasis has been observed. Imaging techniques gain importance in diagnosing cardiac metastasis before disturbance of the cardiac function and involvement of the cardiac valves so that the tumour may be resected surgically in the early period. In this report, we present a case of a 29-year-old woman with cardiac osteosarcoma metastasis 7 years after the initial diagnosis.
Case Report
A 22-year-old woman presented with back pain and a 5 x 6 cm tender mass on the back in August 2001. A dynamic magnetic resonance imaging (MRI) examination of the thoracic wall was applied to demonstrate the lesion. MR images showed a tumoural lesion that destroyed the posterior part of the right 9 th rib and invaded subpleural space and posterior paraspinal muscles to the right. The tumour was hypointense on T1 weighted images and hyperintense on T2 weighted images. In dynamic T1 2D FLASH sequences, the tumour enhanced heterogeneously ( Figure 1A-D) . Thoracic vertebra computed tomography showed the high density calcification areas in the tumour suggesting the osteosarcoma (Figure 2) . After the open surgical biopsy, an osteoblastic osteosarcoma was diagnosed histopathologically. At the time of diagnosis, she did not have any pulmonary or extra pulmonary metastases upon CT examination. Six months after the pre-operative chemotherapy, the patient underwent operation in March 2002. A T9-T10 right laminectomy with partial resection of posterior parts of [8] [9] [10] th ribs was performed. After post-operative chemotherapy, a CT scan demonstrated only post-operative changes. She had a 4-year period in which no metastases or recurrence were observed during annual CT examinations.
In February 2006, a CT scan revealed an anterior mediastinal 3 x 4 cm calcified mass extending to the right lung pericardium and upper lobe (Figure 3 ). It was surgically resected following wedge resection of the right upper lobe. Osteosarcoma metastasis was confirmed histopathologically. In May 2007, a second operation was performed in response to a recurrence of that mass.
In June 2007, a right paraaortic mass was suspected upon contrast-enhanced thorax CT examination ( Figure 4A , B). A posterior-anterior (PA) chest X-ray could not demonstrate the mass since it was projected over the heart and the lower thoracic vertebrae ( Figure 5 ). A thorax CT examination without contrast was applied; it clearly demonstrated the metastatic tumour via dense calcification ( Figure 6 ). The mass was extending between aortic root and right atrial appendage in the pericardial space. There was no valvular involvement or pericardial effusion. A cardiac MRI examination could not be performed due to the patient's refusal to have surgery performed. After an 8-month period, a MRI examination of the thoracic vertebra was performed due to back pain. As observed via MRI, the patient exhibited expanding metastasis of the osteosarcoma at the T5 vertebra and as a result received chemotherapy for that. A cardiac mass was also demonstrated in sagital images of thoracic MRI ( Figure 7A, B) . She refused surgery for the second time and gave up the therapy against medical advice.
Discussion
Osteosarcomas are high grade malignant tumours commonly seen in children and adults. The site of origin is usually in the distal femur in that age group [1] . Primary osteosarcomas of the thorax are rare. They may arise de novo or in a preexisting bone lesion such as Paget's disease. The ribs, scapula and clavicle are the most frequent sites of osseous origin in the thorax which are seen in young adults [2] . Those patients usually present with back pain along with a palpable mass in the second or third decades. In about 70% of the patients with thoracic osteosarcoma, the development of metastases is usually associated with a poor prognosis (5-year survival: 0%) [3] . Cardiac metastases of the thoracic osteosarcoma are extremely rare and demonstrated in the literature in case reports [4, 5] . These metastases usually accompany other distant metastases [6] .
Metastatic cardiac osteosarcoma arises in the right atrium whereas primary cardiac osteosarcoma most often occurs in the left atrium [7] . It is rare for the tumour to grow into the venous system and cardiac chambers as a bulky mass [8] . Patients are mostly asymptomatic but may present with arrhythmias, infective endocarditis or congestive heart failure according to the location and size of the tumour [9] . In our case, cardiac metastasis was demonstrated in the thorax CT although the patient [6] . The median age at diagnosis was 22 and only one case had the rib as a primary origin of metastasis, which was reported by Sonotoni et al. [10] . Nineteen of the cases had other metastases, with the lung being the most common site [6] . Our case had late vertebral and anterior mediastinal metastasis that was not observed in the heart. Therefore, patients with multiple osteosarcoma metastases also should be screened for cardiac metastasis. Another point is that; case series demonstrate an average of 3.7 years before the diagnosis of cardiac metastasis, which was 7 years in our case [6] . Santos-Machado et al. reported a case of parosteal osteosarcoma with myocardial metastasis after 13 years of follow-up [11] . As a result, radiological screening should be performed during a long follow-up phase especially in patients with multiple metastases.
In the radiological screening of osteosarcoma patients, a chest X-ray is the first step to determine calcific masses. Cardiac or lung metastasis may be missed in PA X-rays due to mediastinal superposition and lateral chest X-ray may be helpful in that case. Two-dimensional echocardiography can detect cardiac masses with respect to the valves and thus help in evaluating cardiac function [12] . However, echocardiography may have limitations in evaluating the relationship of a totally calcified mass to valves due to intense posterior acoustic showing. CT and MRI offer high-resolution images of the heart and can therefore be used to evaluate intracardiac masses [13] . Both primary tumour and distant metastases of osteosarcoma produce bone tissue; therefore, thoracic CT examination should be done without contrast injection to differentiate small calcific foci in the heart. However, in the case of a large calcified mass, contrast-enhanced CT may help to evaluate the relation of the mass with the outflow tracts or the valves. Cardiac MRI has improved recently with breath-hold techniques, thereby aiding further evaluation and pre-surgical planning [14] . Multi-dedector CT and MRI may help to determine tumour resectability and allow planning for cardiac chamber reconstruction as a preoperative imaging assessment.
Conclusion
Cardiac metastasis of osteosarcoma is extremely rare. At the initial diagnosis, the older age of the patient with rare primary tumour location and accompanying systemic metastases are important prognostic factors for cardiac metastasis. Those patients should be followed-up for cardiac involvement for long years. Thoracic CT examination without contrast is suitable for radiological follow-up since it determines pulmonary or extrapulmonary calcific metastasis during the early period.
